Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
09/01/1993 | EP0558062A2 Phenoxyacetic acid derivatives and pharmaceutical compositions containing them |
09/01/1993 | EP0557876A1 Use of xanthine derivatives for the treatment of muscle damage subsequent to complete interruption of blood circulation |
09/01/1993 | EP0557787A1 Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments |
09/01/1993 | EP0557498A1 Bone-growth-stimulating composition |
09/01/1993 | EP0557418A1 A $g(b)-TYPE TRANSFORMING GROWTH FACTOR |
09/01/1993 | EP0557383A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated |
09/01/1993 | CN1075717A Benzodiazepine derivatives |
09/01/1993 | CN1021973C Production of proteins in procaryotes |
09/01/1993 | CN1021969C Sialosylcerebrosioles and preparation method thereof |
08/31/1993 | US5241084 Protecting 10-hydroxy group by esterification, activating 7-hydroxy group by forming thiocarbonyl ester, deoxygenating, deprotecting |
08/31/1993 | US5240962 Alkyl or alkenyl-phenols |
08/31/1993 | US5240958 Treating rheumatoid arthritis, promoting wound healing |
08/31/1993 | US5240953 Substituted triazoles as angiotensin ii inhibitors |
08/31/1993 | US5240950 Carbazate derivatives, their production and use |
08/31/1993 | US5240941 Thioxo quinoline compounds, composition and method of use |
08/31/1993 | US5240929 Lipoxygenase inhibitors |
08/31/1993 | US5240923 Treating glaucoma |
08/31/1993 | US5240696 Treatment of periodontitis |
08/31/1993 | CA1321849C Adhesive compositions, controlled release compositions and transdermal drug delivery device |
08/31/1993 | CA1321764C Dna sequence to target proteins to the mammary gland for efficient secretion |
08/31/1993 | CA1321753C Method for inhibiting loss of cognitive functions employing an ace inhibitor |
08/31/1993 | CA1321748C Antifungal compositions and method of controlling myotic infections |
08/29/1993 | CA2090743A1 Pharmaceutical compounds |
08/29/1993 | CA2090283A1 Phenoxyacetic acid derivatives |
08/28/1993 | CA2090279A1 Sulphonylbenzyl-substituted imidazopyridines |
08/28/1993 | CA2090274A1 Sulphonylbenzyl-substituted imidazoles |
08/25/1993 | EP0557171A1 Azaindoles, process for their preparation and medicines containing them |
08/25/1993 | EP0557075A1 4H-naphtho 1,2-b pyran derivatives as antiproliferative agents |
08/25/1993 | EP0556947A1 Use of M1-selective antimuscarinic pyridobenzodiazepinones for the treatment and prevention of axial myopia |
08/25/1993 | EP0556842A2 Contrasting composition for MRI of the gastrointestinal tract |
08/25/1993 | EP0556813A1 Amphoteric tricyclic compounds as antihistaminic and antiallergic agents |
08/25/1993 | EP0556789A2 Substituted biphenyl derivatives, therapeutic agents containing them and process for their preparation |
08/25/1993 | EP0483271B1 Peptides containing diamino-glycols as transition-state mimics |
08/24/1993 | US5239075 Process for the preparation of benzo (f) quinolinones |
08/24/1993 | US5238953 N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohept (b) indole |
08/24/1993 | US5238942 Hypotensive agents |
08/24/1993 | US5238932 Mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
08/24/1993 | US5238923 Amino-substituted heterocycles as renin inhibitors |
08/24/1993 | CA1321603C N-2,3-butadienyl tri- and tetraaminoalkane derivatives |
08/24/1993 | CA1321589C2 Intermediates for preparing benzo ¬5,6| cycloheptapyridines |
08/24/1993 | CA1321582C Disulfur analogs of ll-e33288 antitumor agents |
08/24/1993 | CA1321579C 19-fluoro- or cyano- 21-hydroxyprogesterone derivatives useful as 19-hydroxylase inhibitors |
08/24/1993 | CA1321578C 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors |
08/23/1993 | CA2089959A1 Use of xanthine derivatives for the treatment of muscle damage after interruption of the blood circulation |
08/20/1993 | CA2089974A1 Pharmaceutical compounds |
08/20/1993 | CA2089689A1 Substituted biphenylyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
08/19/1993 | WO2003016307A1 β3 ADRENERGIC AGONISTS |
08/19/1993 | WO1993016107A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
08/19/1993 | WO1993016105A1 Phenylalanine analogs of bombesin |
08/19/1993 | WO1993016103A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
08/19/1993 | WO1993016099A2 Dna sequences encoding novel growth/differentiation factors |
08/19/1993 | WO1993016075A1 4-(1H-2-METHYLIMIDAZO[4,5-c]PYRIDINYLMETHYL)PHENYLSULPHONAMIDE DERIVATIVES AS ANTAGONISTS OF PAF |
08/19/1993 | WO1993016072A1 Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists |
08/19/1993 | WO1993016049A1 Novel pyridone derivatives, preparation method therefor, novel intermediates thereby obtained, their use as drugs, and pharmaceutical compositions containing same |
08/19/1993 | WO1993016029A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
08/19/1993 | WO1993015761A1 Malaria treatments |
08/19/1993 | WO1993015727A1 Antimalarial synergistic compositions containing benflumetol |
08/19/1993 | WO1993015109A3 Parathyroid hormone fragments, their preparation and medicaments containing the same |
08/19/1993 | WO1993014070A3 Novel imidazole derivatives, their preparation and therapeutic applications |
08/19/1993 | CA2129898A1 4-(1h-2-methylimidazo¬4,5-c|pyridinylmethyl)phenylsulphonamide derivatives as antagonists of paf |
08/19/1993 | CA2129830A1 Substituted phenylethenyl compounds having retinoid-like biological activity |
08/19/1993 | CA2129533A1 Improved alpha interferon composition and method for its production from human peripheral blood leukocytes |
08/19/1993 | CA2129112A1 Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists |
08/19/1993 | CA2129032A1 Phenylalanine analogs of bombesin |
08/19/1993 | CA2106758A1 Novel pyridone derivatives, a process for their preparation, novel intermediates thereof, their application as drugs and pharmaceutical compositions holding same |
08/19/1993 | CA2105773A1 Antimalarial synergistic compositions containing benflumetol |
08/18/1993 | EP0556119A1 Novel pyrrolidine derivatives substituted in the 3-position with a saturated or insaturated fatty acid group, process for their preparation and pharmaceuticals with thromboxane A2 inhibiting activity containing them |
08/18/1993 | EP0556092A1 1,4-Dihydropyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
08/18/1993 | EP0556080A1 Bicyclic pyridine derivatives, process for their preparation, intermediates, their use as medicaments and pharmaceutical compositions containing them |
08/18/1993 | EP0556024A1 Novel amidinonaphthyl furancarboxylate derivatives and acid addition salts thereof |
08/18/1993 | EP0555898A2 Medicaments for non-topical use |
08/18/1993 | EP0555845A2 Steroid derivatives |
08/18/1993 | EP0555825A1 Imidazo(1,2-a)pyridines as angiotensin-II-antagonists |
08/18/1993 | EP0555824A1 N-alpha-arylsulfonylated benzimidazolylalaninamide derivatives, medicaments based thereon and process for their preparation |
08/18/1993 | EP0555785A1 Smooth muscle mitogen and DNA coding therefor |
08/18/1993 | EP0555681A1 Use of a combination of potassium channel activators and sulfhydryl containing compounds for the manufacture of a medicament for the treatment of ischemia and myocarolial infarct |
08/18/1993 | EP0555479A1 Epoxysuccinamic acid derivative |
08/18/1993 | EP0555327A1 Alkylidene analogs of 1'-aminospiro-[isoquinoline- 4(1h),3'-pyrrolidine]-1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors in vivo |
08/18/1993 | EP0555231A1 REGULATION OF NEOPLASTIC CELL PROLIFERATION VIA A NOVEL 5HT1a RECEPTOR |
08/18/1993 | EP0555205A1 Dna encoding a growth factor specific for epithelial cells |
08/18/1993 | EP0262178B1 Amino acid chelated compositions for delivery to specific biological tissue sites |
08/18/1993 | CN1075320A 4,13-dioxy-bicyclo (8,2,1) tridecylenone derivative, its prepn. method and its intermediate product and said compound-contained medicament |
08/18/1993 | CN1075318A Benzopyran and related LTB4 antagonists |
08/18/1993 | CN1075254A Compound with cooperation of anti-malaria |
08/18/1993 | CA2089533A1 Derivatives of saturated nitrogen heterocycles |
08/17/1993 | US5236943 Administering angiotensin II receptor blockers |
08/17/1993 | US5236937 Pyridinyl compounds which are useful as angiotensin ii antagonists |
08/17/1993 | US5236933 Use of a combination of angiotensin-converting enzyme inhibitor and calcium antagonist for the treatment of proteinuria |
08/17/1993 | US5236927 Reduced toxicity; side effect reduction |
08/17/1993 | US5236921 Administrering for treatment of neutrogenic inflammation of the respiratory trart |
08/17/1993 | US5236917 Respiratory system disorders, antiarthritic agents |
08/17/1993 | US5236706 Pharmaceutical preparation for the maturation of prothymocytes |
08/17/1993 | US5236705 Fibrinolysis |
08/17/1993 | CA1321391C Substituted pyridine-2,4-dicarboxylic acid derivatives, processes for their preparation, the use thereof and medicaments based on these compounds |
08/17/1993 | CA1321349C Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
08/15/1993 | CA2089470A1 Azaindoles, preparation processes and medicinal products containing them |
08/14/1993 | CA2089466A1 Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
08/14/1993 | CA2088455A1 Combination of potassium channel activator and sulfhydryl containing compound and methods of employing such combination |
08/12/1993 | DE4244090A1 Deactivating agent for active oxygen - is amino-thiosulphonic acid cpd. useful in treatment of, e.g. lung or cardiovascular disorders, or diabetes |
08/12/1993 | CA2089141A1 Imidazo[1,2-a]pyridines, pharmaceutical compositions containing these compounds and processes for preparing them |